Filing Flows

Filing Flows › F5 (FFIV) › Q3 FY26 › vs Q2 FY26

F5 (FFIV) Q3 FY26 vs Q2 FY26 (quarter over quarter)

F5's revenue rose $53.4M (+7%) from $812M in Q2 FY26 to $865M in Q3 FY26. The biggest changes: Product +$52.3M (+13%); Service +$1.1M (+0.3%). Gross margin 82.2% against 81.4% (+0.8 pts).

F5, Q3 FY26: revenue $865M (+11% year over year), operating margin 24.7%, net earnings $208M, operating cash flow $316M. The chart draws each line against Q2 FY26, the increases inside each band.

F5: what changed, Q3 FY26 vs Q2 FY26F5: what changed, Q3 FY26 vs Q2 FY26Working capital & other−$107MFree cash flow (OCF − capex)−$67.0MNet earnings$60.5MProduct$52.3MGross profit$50.7MOperating cash flow−$49.7MPre-tax earnings$37.0MOperating profit$34.2MIncome tax−$23.5MCapital expenditures$17.3M

Margins

Q3 FY26Q2 FY26Change
Gross margin82.2%81.4%+0.8 pts
Operating margin24.7%22.1%+2.6 pts
Net margin24.1%18.2%+5.9 pts
Free cash flow margin32.4%42.8%-10.4 pts

Every line

LineQ3 FY26Q2 FY26Change%
Product$463M$411M$52.3M+13%
Service$402M$401M$1.1M+0.3%
Revenue$865M$812M$53.4M+7%
Gross profit$712M$661M$50.7M+8%
Cost of revenue$154M$151M$2.7M+2%
Other income, net$12.9M$10.2M$2.7M+27%
Operating profit$213M$179M$34.2M+19%
Operating expenses$498M$482M$16.5M+3%
Pre-tax earnings$226M$189M$37.0M+20%
Research & development$165M$151M$13.6M+9%
Sales & marketing$238M$239M−$1.4M-0.6%
General & admin$95.6M$91.6M$3.9M+4%
Net earnings$208M$148M$60.5M+41%
Income tax$18.0M$41.5M−$23.5M-57%
Depreciation & amortization$23.4M$24.6M−$1.1M-5%
Share-based compensation$65.5M$68.0M−$2.5M-4%
Working capital & other$19.1M$126M−$107M-85%
Operating cash flow$316M$366M−$49.7M-14%
Free cash flow (OCF − capex)$281M$348M−$67.0M-19%
Capital expenditures$35.6M$18.3M$17.3M+94%

Questions

How much did F5's revenue grow quarter over quarter in Q3 FY26?

F5's revenue rose $53.4M (+7%) from $812M in Q2 FY26 to $865M in Q3 FY26.

What drove F5's revenue change in Q3 FY26?

Product +$52.3M (+13%); Service +$1.1M (+0.3%).

Q3 FY26 results → · Compare in the interactive Sankey →